Literature DB >> 9298349

Procalcitonin--influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations.

M Meisner1, K Tschaikowsky, S Schnabel, J Schmidt, A Katalinic, J Schüttler.   

Abstract

In this study we have analysed the influence of temperature and time of storage and of repeated freezing on procalcitonin plasma concentrations ex vivo. We have also analysed the difference of procalcitonin concentrations in arterial or venous blood samples and the influence of different anticoagulation techniques on procalcitonin concentrations (serum, EDTA-, lithium-heparin- or citrate plasma). At room temperature (25 degrees C) a loss of procalcitonin plasma concentrations of 6.4% +/- 2.6% (mean, 2 standard error of the mean) after 3 hours (4.6% +/- 5.2% at 4 degrees C) and 12.3% +/- 3.1% after 24 hours occurred (6.3% +/- 5.0% at 4 degrees C, n = 17 each). Comparing the procalcitonin concentrations of blood samples with different anticoagulants (n = 24 each), there was only a significant difference between procalcitonin concentrations in heparinized plasma and serum (+ 7.6%, difference of the mean). There was no significant influence of the blood sampling technique (arterial or venous line) and of repeated freezing/thawing cycles (up to 3 times) on the procalcitonin concentrations measured. Although the difference of sampling and storage of the blood on procalcitonin concentrations is not significant, multiple factors may act synergistically on the result of procalcitonin measurement. To keep variations of ex vivo conditions as minimal as possible, a standardized technique of anticoagulation, time and temperature of storage is recommended, e.g. the use of EDTA-plasma and storage at room temperature, when samples are measured within 4 hours after blood drawing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298349     DOI: 10.1515/cclm.1997.35.8.597

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  16 in total

1.  Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.

Authors:  Alicia Algeciras-Schimnich; Carol M Preissner; J Paul Theobald; Mary S Finseth; Stefan K G Grebe
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

2.  Procalcitonin can be used as a marker of premature atherosclerosis in acromegaly.

Authors:  H Ozkan; O Celik; E Hatipoglu; F Kantarci; P Kadioglu
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

3.  Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial.

Authors:  Zsolt Molnar; Tamas Szakmany; Tamas Koszegi
Journal:  Intensive Care Med       Date:  2003-04-08       Impact factor: 17.440

4.  Discriminative value of inflammatory biomarkers for suspected sepsis.

Authors:  Ephraim L Tsalik; L Brett Jaggers; Seth W Glickman; Raymond J Langley; Jennifer C van Velkinburgh; Lawrence P Park; Vance G Fowler; Charles B Cairns; Stephen F Kingsmore; Christopher W Woods
Journal:  J Emerg Med       Date:  2011-11-06       Impact factor: 1.484

Review 5.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

6.  Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram.

Authors:  D Turner; C Hammerman; B Rudensky; Y Schlesinger; C Goia; M S Schimmel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03-17       Impact factor: 5.747

7.  Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.

Authors:  G Fleischhack; D Cipic; J Juettner; C Hasan; U Bode
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

8.  Immunocytochemical Localization of Prohormone Convertase 1/3 and 2 in Thyroid C-Cells and Medullary Thyroid Carcinomas.

Authors:  Tatsuo Tomita
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

9.  Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients.

Authors:  Yeter Düzenli Kar; Zeynep Canan Özdemir; Özcan Bör
Journal:  Turk Pediatri Ars       Date:  2017-12-01

10.  Procalcitonin levels associate with severity of Clostridium difficile infection.

Authors:  Krishna Rao; Seth T Walk; Dejan Micic; Elizabeth Chenoweth; Lili Deng; Andrzej T Galecki; Ruchika Jain; Itishree Trivedi; Marie Yu; Kavitha Santhosh; Cathrin Ring; Vincent B Young; Gary B Huffnagle; David M Aronoff
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.